Related Experiment Video
Updated: Aug 18, 2026

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment
Luis F Cerdán1, Miguel A Guevara, Araceli Sanz
1Centro Comunitario de Salud Mental No. 1, Instituto Mexicano del Seguro Social, Mexico.
Abstract:
The aim of the present study was to identify brain electrical activity changes generated by olanzapine (OLZ) in treatment refractory schizophrenics (TRS). 14 paranoid TRS (31.5+/-8.39 years old) were evaluated before and after 8 weeks of OLZ treatment. Psychopathology was evaluated by means of total BPRS and PANSS scores. Resting EEG was recorded in the pre (under typical neuroleptics) and post (under OLZ) sessions. A good response to OLZ was observed in 57% of TRS. A significant reduction in positive and negative symptoms scales of PANSS was found. Absolute power of theta1, theta2, alpha1 bands increased after treatment, while beta2 power showed a decrease. Intrahemispheric correlation increased between different zones of the frontal areas and between frontal and posterior areas, while interhemispheric correlation decreased in theta2. EEG changes were more evident in those patients who had a better response to OLZ. OLZ showed to be effective in TRS, improving psychiatric symptoms and increasing activity synchronization between different areas within each hemisphere that may indicate a functional reorganization, particularly in good responders.
Insights
Olanzapine (OLZ) effectively treats refractory schizophrenia by improving symptoms and synchronizing brain activity. EEG changes correlated with symptom improvement, indicating functional reorganization in responsive patients.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Electrophysiology
Background:
- Treatment-refractory schizophrenia (TRS) presents significant challenges in patient management.
- Olanzapine (OLZ) is an atypical antipsychotic used for schizophrenia treatment.
- Understanding OLZ's neurophysiological effects in TRS is crucial for optimizing therapy.
Purpose of the Study:
- To investigate changes in brain electrical activity (EEG) induced by olanzapine (OLZ) in patients with treatment-refractory schizophrenia (TRS).
- To correlate EEG alterations with clinical response to OLZ treatment.
Main Methods:
- 14 paranoid TRS patients underwent EEG recordings before and after 8 weeks of OLZ treatment.
- Psychopathology was assessed using the Brief Psychiatric Rating Scale (BPRS) and the Positive and Negative Syndrome Scale (PANSS).
- Resting EEG data were analyzed for absolute power in different frequency bands and hemispheric correlations.
Main Results:
- 57% of TRS patients showed a good response to OLZ, with significant reductions in PANSS positive and negative symptom scores.
- EEG analysis revealed increased absolute power in theta1, theta2, and alpha1 bands, and decreased power in the beta2 band post-treatment.
- Increased intrahemispheric correlations were observed in frontal areas and between frontal and posterior regions, alongside decreased interhemispheric correlation in the theta2 band.
- EEG changes were more pronounced in patients with a better clinical response.
Conclusions:
- Olanzapine (OLZ) demonstrates efficacy in improving psychiatric symptoms in treatment-refractory schizophrenia (TRS).
- OLZ treatment leads to increased synchronization of brain activity within each hemisphere, suggesting functional reorganization.
- The observed EEG changes correlate with clinical improvement, particularly in good responders, highlighting the potential of EEG as a biomarker for treatment response.
Related Concept Videos
Electroconvulsive Therapy
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).